Tokyo Tape
Sign in
← Kaken Pharmaceutical

Quarterly report · Q1

4521.TEDINET S100RKL3
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥18.1bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥73.0bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥18.2bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income¥3.3bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥4.1bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income¥3.5bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥8.7bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥4.3bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax¥3.5bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥4.0bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)¥2.5bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥5.4bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income¥2.5bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥2.9bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥167.2bnat 2023-06-30Cons.Assets
Total assets¥166.3bnat 2023-03-31Cons.Assets
Total assets¥165.1bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥29.3bnat 2023-06-30Cons.Liabilities
Total liabilities¥29.5bnat 2023-03-31Cons.Liabilities
Net assets / equity¥137.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥136.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥137.9bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥56.8bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥59.6bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥66.992023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.82022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥76.912022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio82.1%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio81.9%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio83.1%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 18
SegmentItemPeriodValue
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2023-04-01 → 2023-06-30¥17.5bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2023-04-01 → 2023-06-30¥17.5bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2023-04-01 → 2023-06-30¥3.0bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2023-04-01 → 2023-06-30¥605m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2023-04-01 → 2023-06-30¥321m
—segment totalrevenue2023-04-01 → 2023-06-30¥18.1bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥18.1bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.3bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentrevenue external2022-04-01 → 2022-06-30¥17.6bn
jpcrp040300-q1r_E00935-000Medicinereportable segmentsegment profit2022-04-01 → 2022-06-30¥3.8bn
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentrevenue external2022-04-01 → 2022-06-30¥615m
jpcrp040300-q1r_E00935-000Real Estatereportable segmentsegment profit2022-04-01 → 2022-06-30¥295m
—segment totalrevenue2022-04-01 → 2022-06-30¥18.2bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥18.2bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥4.1bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 374
ItemContextValueUnit
Income taxes payablePrior1YearInstant2004000000JPY
Income taxes payableCurrentQuarterInstant1151000000JPY
Provision for bonusesPrior1YearInstant942000000JPY
Provision for bonusesCurrentQuarterInstant460000000JPY
Other clPrior1YearInstant7822000000JPY
Other clCurrentQuarterInstant7804000000JPY
Current liabilitiesPrior1YearInstant20838000000JPY
Current liabilitiesCurrentQuarterInstant20465000000JPY
Provision for share based remuneration nclPrior1YearInstant117000000JPY
Provision for share based remuneration nclCurrentQuarterInstant85000000JPY
Net defined benefit liabilityPrior1YearInstant6349000000JPY
Net defined benefit liabilityCurrentQuarterInstant6367000000JPY
Deferred tax liabilitiesPrior1YearInstant1771000000JPY
Deferred tax liabilitiesCurrentQuarterInstant1771000000JPY
Other nclPrior1YearInstant414000000JPY
Other nclCurrentQuarterInstant627000000JPY
Noncurrent liabilitiesPrior1YearInstant8653000000JPY
Noncurrent liabilitiesCurrentQuarterInstant8851000000JPY
LiabilitiesPrior1YearInstant29491000000JPY
LiabilitiesCurrentQuarterInstant29317000000JPY
Capital stockPrior1YearInstant23853000000JPY
Capital stockCurrentQuarterInstant23853000000JPY
Capital surplusPrior1YearInstant11406000000JPY
Capital surplusCurrentQuarterInstant11406000000JPY
Retained earningsPrior1YearInstant126135000000JPY
Retained earningsCurrentQuarterInstant125832000000JPY
Treasury stockPrior1YearInstant-30026000000JPY
Treasury stockCurrentQuarterInstant-30027000000JPY
Shareholders equityPrior1YearInstant131368000000JPY
Shareholders equityCurrentQuarterInstant131065000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant4724000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant6025000000JPY
Remeasurements of defined benefit plansPrior1YearInstant165000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant163000000JPY
Valuation and translation adjustmentsPrior1YearInstant4889000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant6189000000JPY
Non controlling interestsPrior1YearInstant578000000JPY
Non controlling interestsCurrentQuarterInstant578000000JPY
Net assetsPrior1YearInstant136836000000JPY
Net assetsCurrentQuarterInstant137833000000JPY
Liabilities and net assetsPrior1YearInstant166328000000JPY
Liabilities and net assetsCurrentQuarterInstant167151000000JPY
Net salesPrior1YTDDuration18197000000JPY
Net salesCurrentYTDDuration18150000000JPY
Cost of salesPrior1YTDDuration8157000000JPY
Cost of salesCurrentYTDDuration8094000000JPY
Gross profitPrior1YTDDuration10040000000JPY
Gross profitCurrentYTDDuration10056000000JPY
Salaries sgaPrior1YTDDuration1407000000JPY
Salaries sgaCurrentYTDDuration1417000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass